Company Information

  

Address: 11535 SORRENTO VALLEY ROAD
SUITE 400 
City: SAN DIEGO 
State: CA 
Zip Code: 92121 
Telephone: 858-259-9405 

Description of Business

Primary SIC Code: 2834
(As filed with the SEC)  

We are a Delaware corporation, originally incorporated in 1988 under the name Terrapin Diagnostics, Inc. in the state of Delaware, and subsequently renamed "Telik, Inc." in 1998, and thereafter renamed MabVax Therapeutics Holdings, Inc. in September 2014. Our principal corporate office is located at 11535 Sorrento Valley Road, Suite 400, San Diego, CA 92121 and our telephone number is (858) 259-9405. On July 8, 2014, we consummated a merger with MabVax Therapeutics, pursuant to which our subsidiary Tacoma Acquisition Corp. merged with and into MabVax Therapeutics, with MabVax Therapeutics surviving as our wholly owned subsidiary. This transaction is referred to as the "Merger." Our internet address is www.mabvax.com. Information on our website is not incorporated into this report.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
09/2017-3.45NAN/E
06/2017-3.98NAN/E
03/2017-3.37NAN/E
12/2016-3.64NAN/E
09/2016-2.38NAN/E
06/20162.74NA1.49

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2016 Leverage 2016
Net Inc/Comm Equity-0.22Total Liab/Total Assets0.72
Net Inc/Total Assets-1.47Total Liab/Inv Cap1.84
Net Inc/Inv Cap-3.74Total Liab/Comm Equity0.11
Pretax Inc/Net Sales-119.28Interest Coverage Ratio-16.71
Net Inc/Net Sales-119.28Curr Debt/Equity0.48
Cash Flow/Net Sales-83.51LTD/Equity0.85
SG&A/NetSales60.86Total Debt/Equity1.33
Asset Utilization   Liquidity  
Net Receivables Turnover0.39Quick Ratio0.75
Inventory TurnoverNACurrent Ratio0.75
Inventory Day SalesNANet Rec/Curr AssetsNA
Net Sales/Work Cap-0.11Inv/Curr AssetsNA
Net Sales/PP&E0.20  

Income Statement (Millions)

  9/30/2017 6/30/2017 3/31/2017 12/31/2016
Total Revenues(Net Sales) 0.00 0.00 0.00 0.00
Cost of Goods Sold NA NA NA NA
Selling & Admin Exps 1.83 3.41 2.27 2.01
Operating Income -2.85 -5.74 -5.09 -4.84
Interest Exp 0.23 0.51 NA 0.27
Pretax Income -3.08 -5.99 -5.35 -5.11
Other Income NA NA NA 0.00
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -3.08 -5.99 -5.35 -5.11

Balance Sheet (Millions)

Assets 9/30/2017 6/30/2017 3/31/2017 12/31/2016
Cash & Short Term Investments 3.05 1.85 0.60 3.98
Receivables - Total NA NA NA 0.00
Inventories - Total NA NA NA NA
Total Current Assets 3.47 2.00 0.81 4.29
Net Property, Plant & Equipment 0.62 0.66 0.69 0.73
Total Assets 11.10 9.66 8.66 12.02
Liabilities        
Accounts Payable 4.68 5.37 5.07 4.08
Debt in Current Liabilities 1.71 1.68 1.68 1.61
Total Current Liabilities 6.39 7.06 6.75 5.69
Long-Term Debt 2.01 2.34 2.67 2.84
Total Liabilities 8.58 9.57 9.58 8.68
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock 0.03 0.04 0.01 0.01
Common Stock 0.19 0.09 0.06 0.06
Retained Earnings -101.05 -94.85 -83.62 -78.26
Treasury Stock NA NA NA NA
Total Stockholders' Equity 2.52 0.09 -0.92 3.34
Total Liabilities and Stockholders' Equity 11.10 9.66 8.66 12.02

Cash Flow Summary (Millions)

Categories 9/30/2017 6/30/2017 3/31/2017 12/31/2016
Net Cash Provided by Operating Activities -2.68 -2.85 -3.18 -2.74
Net Cash Provided by Investing Activities -0.02 -0.00 0.00 -0.15
Net Cash Provided by Financing Activities 3.90 4.10 -0.20 -0.07

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/20120.00-7.97--
12/20130.37-4.04--
12/20140.31-7.92--
12/20151.27-18.11--
12/20160.15-17.66-3.64
Growth RatesInfinity----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional09/30/17142,64812.87




Report Date : 12/4/2017

Powered By Edgar Online © 2017EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.